Replay available

IMARA Inc. (IMRA) Q4 2021 Earnings Call

IMARA Inc. (NASDAQ: IMRA) Q4 2021 earnings conference call, held 2022-03-15. Replay captured from the company's public earnings webcast.

Tue, March 15, 2022 at 8:30 AMendedReplay
IMARA Inc. (IMRA) Q4 2021 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Mike Gray

Chief Financial and Chief Operating Officer

Rahul Bilal

President and Chief Executive Officer

Ken Addy

Chief Medical Officer

Edon Notomovich

Analyst, Citigroup

Joseph Swartz

Analyst, SVB Securities

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by, and welcome to the EMARA Inc. Q4 and 2021 Earnings Conference Call and Webcast. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone. If you require any further assistance, please press star then 0. I would now like to hand the conference over to your speaker, Mr. Mike Gray, Chief Financial and Chief Operating Officer for EMARA. Please go ahead, sir. Okay. Thank you, Cherie. Good morning, everyone, and welcome to EMARA's fourth quarter 2021 conference call. I'm joined this morning by EMARA's President and CEO, Rahul Bilal, and our Chief Medical Officer, Ken Addy. Before we begin, I'd like to remind everyone that various statements we make during this conference call about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual events or results could differ materially from those expressed or implied by these forward-looking statements as a result of various important factors, including those set forth in the risk factor section of our most recent annual report on Form 10-K, that we filed with the SEC this morning, as well as other filings that we may make with the SEC. Any forward-looking statements made on this call represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so even if our views change. Therefore, ...

More from Enliven Therapeutics, Inc.